SMB Laboratoires

SMB Laboratoires is a private Belgian pharmaceutical company established in 1954, specializing in the development and manufacturing of complex off-patent drugs with high added value. The company focuses on innovative drug delivery systems, particularly for oral and inhalation routes, to improve the bioavailability and patient compliance of established molecules. Through its R&D center, Galephar, SMB has developed proprietary technologies such as Lidose and Minitabs, as well as advanced Dry Powder Inhalers (DPI). Their therapeutic portfolio primarily covers respiratory diseases, cardiovascular health, and pain management. SMB operates fully integrated facilities in Belgium that are GMP-certified and FDA-inspected, supporting both their own product line and CDMO services for global partners.